Aspen Aerogels (NYSE:ASPN) Issues Q1 2025 Earnings Guidance

Aspen Aerogels (NYSE:ASPNGet Free Report) issued an update on its first quarter 2025 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of -0.180-0.000 for the period, compared to the consensus estimate of 0.080. The company issued revenue guidance of $75.0 million-$95.0 million, compared to the consensus revenue estimate of $104.2 million.

Aspen Aerogels Stock Performance

Shares of NYSE ASPN traded down $3.15 during midday trading on Thursday, reaching $8.60. 5,807,017 shares of the company traded hands, compared to its average volume of 1,773,958. The stock has a 50-day moving average price of $12.36 and a 200 day moving average price of $18.63. The company has a market cap of $705.96 million, a price-to-earnings ratio of 874.17 and a beta of 2.14. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.93 and a quick ratio of 2.48. Aspen Aerogels has a 52 week low of $8.55 and a 52 week high of $33.15.

Aspen Aerogels (NYSE:ASPNGet Free Report) last released its quarterly earnings results on Wednesday, February 12th. The construction company reported $0.15 earnings per share for the quarter, beating analysts’ consensus estimates of $0.04 by $0.11. Aspen Aerogels had a return on equity of 5.06% and a net margin of 0.36%. Sell-side analysts anticipate that Aspen Aerogels will post 0.12 earnings per share for the current fiscal year.

Analyst Ratings Changes

ASPN has been the topic of a number of research analyst reports. Barclays lowered their target price on shares of Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating on the stock in a research note on Tuesday, November 12th. Piper Sandler dropped their price objective on Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating on the stock in a research note on Tuesday, October 22nd. HC Wainwright restated a “buy” rating and set a $30.00 target price on shares of Aspen Aerogels in a research note on Wednesday, October 16th. Roth Mkm lowered their target price on Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating on the stock in a report on Friday, November 8th. Finally, StockNews.com upgraded Aspen Aerogels to a “sell” rating in a report on Saturday, February 8th. One investment analyst has rated the stock with a sell rating, eight have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $29.11.

View Our Latest Report on Aspen Aerogels

Aspen Aerogels Company Profile

(Get Free Report)

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

Featured Articles

Earnings History and Estimates for Aspen Aerogels (NYSE:ASPN)

Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.